Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlamydia infection and subfertility.

Jolande A Land1, Johannes L H Evers

  • 1Department of Obstetrics and Gynaecology, Research Institute GROW, Academisch Ziekenhuis Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.

Best Practice & Research. Clinical Obstetrics & Gynaecology
|December 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancies and Time to Pregnancy in Women With and Without a Previous Chlamydia trachomatis Infection.

Sexually transmitted diseases·2020
Same author

Reduced oxygen concentration during human IVF culture improves embryo utilization and cumulative pregnancy rates per cycle.

Human reproduction open·2020
Same author

Antibody Testing in Estimating Past Exposure to C<i>hlamydia trachomatis</i> in the Netherlands Chlamydia Cohort Study.

Microorganisms·2019
Same author

Predictive Values of Serum <i>Chlamydia trachomatis</i> TroA and HtrA IgG Antibodies as Markers of Persistent Infection in the Detection of Pelvic Adhesions and Tubal Occlusion.

Microorganisms·2019
Same author

Prevalence of Chlamydia trachomatis infections in the Middle East and north Africa, what next?

The Lancet. Global health·2019
Same author

The Potential Role for Host Genetic Profiling in Screening for Chlamydia-Associated Tubal Factor Infertility (TFI)-New Perspectives.

Genes·2019

Chlamydia infections often go unnoticed but can lead to infertility. Chlamydial heat shock protein 60 (HSP60) antibody testing shows promise in predicting tubal factor subfertility, potentially improving diagnosis.

Area of Science:

  • Reproductive Medicine
  • Immunology
  • Infectious Diseases

Background:

  • Chlamydia trachomatis infections are frequently asymptomatic in women.
  • These infections can increase the risk of tubal factor subfertility.
  • Pelvic inflammatory disease (PID) and its chronic effects are linked to chlamydial IgG antibodies, with higher antibody levels correlating to subfertility.

Purpose of the Study:

  • To evaluate the predictive value of chlamydial heat shock protein 60 (HSP60) antibody testing for tubal factor subfertility.
  • To explore HSP60 antibody testing as a potential diagnostic tool beyond standard chlamydia antibody testing (CAT).

Main Methods:

  • Review of existing literature on chlamydia antibody testing (CAT) and its limitations.
  • Evaluation of chlamydial HSP60 antibody testing in the context of chronic inflammation and subfertility.

Related Experiment Videos

  • Analysis of factors affecting the sensitivity and specificity of CAT.

    • Main Results:

    • Standard chlamydia antibody testing (CAT) has limited predictive value for tubal factor subfertility.
    • Chlamydial heat shock proteins (HSPs) are hypothesized to indicate chronic inflammation.
    • Chlamydial HSP60 antibody testing has been investigated for its potential in predicting tubal factor subfertility.

    Conclusions:

    • The predictive value of conventional chlamydia antibody testing (CAT) for tubal factor subfertility is limited.
    • Chlamydial HSP60 antibody testing is being explored as a more sensitive indicator of chronic inflammation and potential subfertility.
    • Further research into HSP60 antibody testing may offer improved diagnostic capabilities for women at risk of infertility due to chlamydial infections.